EDOC:AU:AU-BetaShares Digital Health and Telemedicine ETF (AUD)

ETF | Others |

Last Closing

USD 8.62

Change

-0.10 (-1.15)%

Market Cap

N/A

Volume

103.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+0.25 (+0.26%)

USD 14.95B
IVV:AU iShares Core S&P 500 AUD

+0.14 (+0.26%)

USD 8.23B
VGS:AU Vanguard MSCI International Sh..

+0.29 (+0.23%)

USD 7.81B
QUAL:AU VanEck Vectors MSCI World ex A..

+0.04 (+0.07%)

USD 6.14B
IOZ:AU Ishares Core S&P/Asx 200

+0.08 (+0.26%)

USD 5.47B
STW:AU SPDR® S&P/ASX 200 Fund

+0.19 (+0.27%)

USD 5.17B
NDQ:AU Betashares Nasdaq 100

+0.35 (+0.79%)

USD 4.94B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

+0.45 (+1.12%)

USD 4.86B
A200:AU BetaShares Australia 200

+0.32 (+0.25%)

USD 4.72B
VTS:AU Vanguard US Total Market Share..

+1.20 (+0.30%)

USD 3.95B

ETFs Containing EDOC:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.40% 4% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.40% 3% F 43% F
Trailing 12 Months  
Capital Gain -19.74% 4% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.74% 3% F 42% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -1.48% 20% F 39% F
Dividend Return -1.48% 14% F 36% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.67% 82% B 96% N/A
Risk Adjusted Return -31.74% 12% F 26% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.